ConforMIS (CFMS) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ConforMIS Reports Fourth Quarter and Fiscal Year 2015 Financial Results; Provides 2016 Financial Revenue Guidance
February 11, 2016 4:06 PM ESTBEDFORD, Mass., Feb. 11, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the fourth quarter and fiscal year ended December 31, 2015.
Q4 Summary:
Total revenue of $19.1 million, up 34% year-over-year on a reported basis and up 38% year-over-year on a constant currency basisProduct revenue of $18.8 million, up 33% year-over-year on a reported basis and up 37% year-over-year on a constant currency... More